OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

Returns on capital

OrganiGram Holdings Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-7.1%

avg -18.3%

ROIC

-13.0%

avg -16.5%

ROA

-4.4%

avg -15.1%

Analysis

ROA is currently the strongest return metric at -4.4% versus its period average of -15.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

James H. Yamanaka

Chief Executive Officer & DirectorCAD 761.3K58——

Timothy Emberg

President of Organigram CanadaCAD 464.92K———

Greg Guyatt

Chief Financial OfficerCAD 464.8K———

Helen Martin

Chief Legal Officer & Corporate SecretaryCAD 462.7K48——

Peter L. Amirault

Executive ChairmanCAD 95K65——

Max Schwartz

Director of Investor Relations————

Megan Amber McCrae

Senior Vice President of Corporate Strategy & International Growth————

Valerie Rother

Chief People Officer————

Adrian Frenzel

Global Chief Operating Officer————

Bradley Gunter

Senior Vice President of Sales————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

No open-market purchases or sales in the last 12 months.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/A+21.1%
+16.7% (5yr)1 analysts
Net IncomeN/AN/AN/A
N/A1 analysts
EBITN/AN/AN/A
N/A1 analysts

Analysis

Recent growth has been strongest in Revenue at +21.1% over three years. Forward estimates point to Revenue at +16.7% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does OrganiGram Holdings Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about OGI.TO's management, answered from reported figures.

Who manages OGI.TO?

OrganiGram Holdings Inc. (OGI.TO) lists 10 active executives. The top listed executive is Max Schwartz, Director of Investor Relations.